HSA Adverse Drug Reaction News 2017 May, Vol.19 No.1

HSA Adverse Drug Reaction News 2017 May, Vol.19 No.1

The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.

This issue includes the following topics:

  • New recommendations on the use of domperidone
  • Risk of hepatitis B virus reactivation with direct-acting antivirals

  • Analysis of adverse event (AE) reports for the year 2016

  • Highlights of local safety signals for the year 2016

  • Dear Healthcare Professional Letters on Safety Concerns (1 December 2016 – 30 April 2017)

  • Risk of falsely elevated oestradiol levels due to cross-reactivity of fulvestrant with oestradiol immunoassays
  •